Refers to a Formulation in the form of Tablet Comprising 2 - fluoro - N - methyl - 4 - (6 - [7 - quinolin-1 - ylmethyl) imidazo [1,2-b] [1,2,4] triazin - 2 - il) benzamide or a pharmaceutically acceptable Salt thereof.Also includes 10% - 30% by weight of 2 - fluoro - N - methyl - 4 - (6 - [7 - quinolin-1 - ylmethyl) imidazo [1,2-b] [1,2,4] triazin - 2 - il) benzamide or a pharmaceutically acceptable Salt thereof, 50% - 70% of one or more agents Filler, 3% - 20% of one or more disintegrant 0.2% - 2% of one or more Lubricants and 0.2% - 2% of one or m As Sliding. Also refers to a process.This formulation Inhibits the kinase c-met, being useful in the treatment of Lung Cancer, Liver, among othersSe refiere a una formulacion en forma de tableta que comprende 2-fluoro-N-metil-4-[7-(quinolin-6-ilmetil)imidazo[1,2-b][1,2,4]triazin-2-il)benzamida o una sal farmaceuticamente aceptable del mismo. Ademas comprende 10%-30% en peso de 2-fluoro-N-metil-4-[7-(quinolin-6-ilmetil)imidazo[1,2-b][1,2,4]triazin-2-il)benzamida o una sal farmaceuticamente aceptable del mismo, 50%-70% de uno o mas agentes de relleno, 3%-20% de uno o mas disgregantes 0,2%-2% de uno o mas lubricantes y 0,2%-2% de uno o mas deslizantes. Tambien se refiere a un proceso. Dicha formulacion inhibe las quinasas c-Met, siendo util en el tratamiento de cancer de pulmon, higado, entre otros
